Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Vitexin Compound 1 may help reduce skin aging caused by UVA light.

Ritlecitinib was generally well tolerated in children with alopecia areata.

A man developed skin issues from cancer medication, which improved with specific treatments.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Promising cancer treatments were found, but the manufacturer closed.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.